T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Baxter International
BAX
$14B
| $695M | 0.1% |
15,254,038
+6,057,263
| +66% | +$264M |
|
202
Rexford Industrial Realty
REXR
$8.12B
| $692M | 0.1% |
13,252,937
+2,229,386
| +20% | +$122M |
|
203
TransDigm Group
TDG
$68.6B
| $685M | 0.1% |
766,516
-52,241
| -6% | -$41.3M |
|
204
TotalEnergies
TTE
$193B
| $685M | 0.1% |
11,890,611
-3,144,989
| -21% | -$190M |
|
205
Huntington Bancshares
HBAN
$36.2B
| $680M | 0.09% |
63,103,940
-3,764,022
| -6% | -$40.2M |
|
206
CVS Health
CVS
$122B
| $675M | 0.09% |
9,764,242
+857,471
| +10% | +$61M |
|
207
Tyson Foods
TSN
$19.9B
| $672M | 0.09% |
13,171,608
+3,699,785
| +39% | +$201M |
|
208
Range Resources
RRC
$9.26B
| $670M | 0.09% |
22,796,358
+18,898,805
| +485% | +$514M |
|
209
General Motors
GM
$75.9B
| $669M | 0.09% |
17,338,330
+2,650,592
| +18% | +$91.7M |
|
210
Descartes Systems
DSGX
$6.4B
| $663M | 0.09% |
8,271,631
-888,697
| -10% | -$69.2M |
|
211
Broadridge
BR
$19.1B
| $660M | 0.09% |
3,985,225
+497,188
| +14% | +$75.2M |
|
212
Apollo Global Management
APO
$83.2B
| $659M | 0.09% |
8,575,520
+767,020
| +10% | +$51.3M |
|
213
Cintas
CTAS
$80.5B
| $654M | 0.09% |
5,265,152
-411,120
| -7% | -$48.2M |
|
214
Williams Companies
WMB
$90B
| $654M | 0.09% |
20,028,700
+17,209,863
| +611% | +$517M |
|
|
APLS
215
DELISTED
Apellis Pharmaceuticals
APLS
| $644M | 0.09% |
7,072,226
+2,482,186
| +54% | +$214M |
|
216
Procore
PCOR
$8.82B
| $641M | 0.09% |
9,852,087
-56,910
| -0.6% | -$3.35M |
|
217
IDEX
IEX
$17.6B
| $640M | 0.09% |
2,973,971
-1,435,619
| -33% | -$302M |
|
218
Kinder Morgan
KMI
$72.1B
| $640M | 0.09% |
37,164,662
+435,102
| +1% | +$7.39M |
|
219
Mercado Libre
MELI
$93.3B
| $640M | 0.09% |
540,129
+110,949
| +26% | +$140M |
|
220
Legend Biotech
LEGN
$3.96B
| $623M | 0.09% |
9,031,324
+7,939,175
| +727% | +$519M |
|
|
NVO
221
Novo Nordisk
NVO
$201B
| $619M | 0.09% |
7,654,890
+83,770
| +1% | +$6.84M |
|
222
Sea Limited
SE
$75.2B
| $598M | 0.08% |
10,307,631
-6,111,707
| -37% | -$436M |
|
223
Datadog
DDOG
$89.3B
| $598M | 0.08% |
6,077,463
-1,103,975
| -15% | -$92.3M |
|
|
P
224
Everpure Inc
P
$38.8B
| $588M | 0.08% |
15,981,042
+1,889,965
| +13% | +$53.5M |
|
|
SEM
225
DELISTED
Select Medical
SEM
| $588M | 0.08% |
34,270,444
-4,110,443
| -11% | -$63.7M |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.